NCT06614296

Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

Factors and Experiences Associated with Unscheduled Hospital Readmission After Crenel Lateral Interbody Fusion

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100 (actual)
• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this observational study is to learn about the readmission related to Crenel Lateral Interbody Fusion (CLIF). The main question it aims to answer is: What are the risk factors for readmission after CLIF surgery?

Conditions

• Spine Degeneration

Interventions

Type	Name	Description
PROCEDURE	Crenel Lateral Interbody Fusion	The Crenel Lateral Interbody Fusion (CLIF) is a surgical technique developed by the Department of Spine Surgery at the Second Affiliated Hospital of Zhejiang University School of Medicine. Building on the traditional Lateral Lumbar Interbody Fusion technique, this series of technical improvements overcomes the shortcomings of previous surgical methods, enhancing the safety, operability, and effectiveness of the surgery while reducing complications.
PROCEDURE	Crenel lateral interbody fusion plus second stage surgery	The patient was first admitted to undergo CLIF surgery and was discharged after the operation. The patient will return to the hospital for a second surgery at the scheduled time.

Timeline

• Start date: 2024-04-03
• Primary completion: 2024-07-25
• Completion: 2024-08-02
• First posted: 2024-09-26
• Last updated: 2024-10-01

Locations

1 site across 1 country: China